Bank of New York Mellon’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15M Sell
687,572
-3,462
-0.5% -$67K ﹤0.01% 1696
2025
Q4
$14.9M Buy
691,034
+100,763
+17% +$2.12M ﹤0.01% 1701
2025
Q3
$11.4M Sell
590,271
-59,007
-9% -$1.05M ﹤0.01% 1860
2025
Q2
$11.1M Sell
649,278
-141,805
-18% -$6.05M ﹤0.01% 1839
2025
Q1
$50.5M Sell
791,083
-1,354,401
-63% -$143M 0.01% 958
2024
Q4
$261M Buy
2,145,484
+26,581
+1% +$3.26M 0.05% 312
2024
Q3
$265M Sell
2,118,903
-11,748
-0.6% -$1.62M 0.05% 315
2024
Q2
$337M Buy
2,130,651
+63,614
+3% +$8.17M 0.06% 255
2024
Q1
$268M Sell
2,067,037
-262,519
-11% -$32.2M 0.05% 309
2023
Q4
$225M Sell
2,329,556
-181,811
-7% -$17.4M 0.05% 346
2023
Q3
$304M Buy
2,511,367
+78,599
+3% +$8.88M 0.07% 266
2023
Q2
$279M Buy
2,432,768
+518,050
+27% +$66.8M 0.06% 295
2023
Q1
$264M Sell
1,914,718
-79,115
-4% -$10.3M 0.06% 301
2022
Q4
$258M Buy
1,993,833
+110,835
+6% +$12.8M 0.06% 293
2022
Q3
$208M Sell
1,882,998
-107,929
-5% -$10.9M 0.05% 343
2022
Q2
$149M Buy
1,990,927
+16,104
+0.8% +$1.18M 0.03% 454
2022
Q1
$154M Sell
1,974,823
-32,912
-2% -$2.52M 0.03% 495
2021
Q4
$181M Buy
2,007,735
+49,770
+3% +$4.25M 0.03% 466
2021
Q3
$181M Sell
1,957,965
-22,824
-1% -$1.76M 0.04% 444
2021
Q2
$154M Buy
1,980,789
+189,495
+11% +$14.4M 0.03% 507
2021
Q1
$134M Buy
1,791,294
+507,151
+39% +$46.8M 0.03% 564
2020
Q4
$219M Buy
1,284,143
+12,811
+1% +$1.9M 0.05% 343
2020
Q3
$179M Sell
1,271,332
-24,833
-2% -$3.77M 0.04% 373
2020
Q2
$208M Buy
1,296,165
+159,776
+14% +$21.7M 0.06% 297
2020
Q1
$111M Sell
1,136,389
-17,792
-2% -$2.03M 0.04% 427
2019
Q4
$149M Sell
1,154,181
-33,444
-3% -$3.38M 0.04% 429
2019
Q3
$89.5M Buy
1,187,625
+221,636
+23% +$26.2M 0.02% 633
2019
Q2
$147M Buy
965,989
+109,743
+13% +$13.3M 0.04% 433
2019
Q1
$102M Buy
856,246
+285,578
+50% +$36.7M 0.03% 572
2018
Q4
$62.3M Buy
570,668
+291,823
+105% +$36.5M 0.02% 763
2018
Q3
$45M Buy
278,845
+3,537
+1% +$484K 0.01% 1098
2018
Q2
$36.4M Sell
275,308
-42,033
-13% -$3.96M 0.01% 1214
2018
Q1
$23.5M Sell
317,341
-445
-0.1% -$29.7K 0.01% 1460
2017
Q4
$17.7M Buy
317,786
+1,983
+0.6% +$105K ﹤0.01% 1646
2017
Q3
$14.3M Buy
315,803
+57,592
+22% +$2.3M ﹤0.01% 1776
2017
Q2
$8.7M Buy
258,211
+10,287
+4% +$335K ﹤0.01% 2051
2017
Q1
$7.34M Buy
247,924
+1,923
+0.8% +$59.5K ﹤0.01% 2126
2016
Q4
$6.75M Buy
246,001
+1,382
+0.6% +$55.5K ﹤0.01% 2168
2016
Q3
$15M Buy
244,619
+22,801
+10% +$689K ﹤0.01% 1631
2016
Q2
$4.23M Buy
221,818
+2,282
+1% +$42.3K ﹤0.01% 2291
2016
Q1
$4.29M Buy
219,536
+1,403
+0.6% +$24.5K ﹤0.01% 2255
2015
Q4
$8.42M Buy
218,133
+13,944
+7% +$452K ﹤0.01% 1936
2015
Q3
$6.56M Sell
204,189
-37,288
-15% -$1.27M ﹤0.01% 2081
2015
Q2
$7.35M Buy
241,477
+13,206
+6% +$270K ﹤0.01% 2119
2015
Q1
$3.03M Buy
228,271
+19,670
+9% +$262K ﹤0.01% 2595
2014
Q4
$3.02M Sell
208,601
-6,412
-3% -$109K ﹤0.01% 2587
2014
Q3
$4.54M Buy
215,013
+14,064
+7% +$317K ﹤0.01% 2370
2014
Q2
$5.99M Sell
200,949
-7,214
-3% -$228K ﹤0.01% 2220
2014
Q1
$5M Buy
208,163
+29,870
+17% +$762K ﹤0.01% 2310
2013
Q4
$3.63M Buy
178,293
+8,131
+5% +$242K ﹤0.01% 2495
2013
Q3
$8.04M Buy
170,162
+4,104
+2% +$158K ﹤0.01% 1942
2013
Q2
$6.32M Buy
+166,058
New +$5.94M ﹤0.01% 2052

Other funds holding SRPT